A 12-week prospective cohort enrolled 73 patients with guideline-based asthma or COPD and no speech-affecting comorbidities, ...

Infections, not eosinophilic inflammation, are the primary cause of asthma exacerbations in patients receiving benralizumab.

The introduction of biologic therapies for severe asthma has transformed clinical practice. Among these agents, benralizumab ...

The introduction of respiratory biologics shows greatest benefits in patients with severe and eosinophilic asthma.

In one phase 3 trial, former smokers with COPD receiving itepekimab had a significantly lower annualized moderate/severe ...

Significant changes in voice are observed during an exacerbation of asthma or chronic obstructive pulmonary disease (COPD), ...

Getting an asthma diagnosis means you have to learn some new lingo. Your doctor may throw around phrases like “peak flow readings” (a way to measure how well your lungs are functioning), “short-acting ...

Clinical guidelines recommend use of exacerbation history in choosing therapies to predict the risk for chronic obstructive pulmonary disease exacerbations, but an analysis of data from three ...

Key TakeawaysVoice changes measured by a smartphone app can predict oncoming asthma or COPD flaresPeople’s voices change ...

Retrospective studies have shown that statins decrease the rate and severity of exacerbations, the rate of hospitalization, and mortality in chronic obstructive pulmonary disease (COPD). We ...